🇺🇸 FDA
Patent

US 6602979

Screening assays for compounds that cause apoptosis

expired A61KA61K38/1709

Quick answer

US patent 6602979 (Screening assays for compounds that cause apoptosis) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jul 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Aug 05 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K38/1709